Overview
Background
Maher Gandhi received his medical degree in the UK in 1989, and then trained as a haematologist, including a Fellowship in malignant haematology at Princess Margaret Cancer Centre, Toronto. He was awarded a PhD in immunology at Cambridge University under Patrick Sissons. In 2003 he moved to Brisbane, and works as a Senior Staff Specialist (Pre-Eminent Status) in the Haematology / Oncology Department of the Princess Alexandra Hospital. He leads his own laboratory group and has established an international reputation studying immunity and identification of novel biomarkers in lymphoma, with continuous NHMRC funding since 2005. He was Chair of Laboratory Sciences for the Australasian Leukaemia and Lymphoma Group between 2010-2016, won the prestigious Australian Society of Medical Research Clinical Research Award in 2010 and in 2012 took up the inaugural John McCaffrey Cancer Council of Queensland / Office of Health and Medical Research Clinical Research Fellowship. Between 2011-2014 he was privileged to serve as Chair of the Metro South Human Research Ethics Committee. In 2013 he was appointed Professor of Experimental Haematology, University of Queensland, based at the Translational Research Institute, in 2014 became the inaugural Leukaemia Foundation Chair of Blood Cancer Research at the University of Queensland Diamantina Institute, and was appointed Diamantina Cancer Program Head in 2016. In 2018 to current, he moved to Mater Research, where he is Executive Director, as well Director of MRI-UQ.
Availability
- Professor Maher Gandhi is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Medicine Surgery, University of Aberdeen
- Doctor of Philosophy, University of Cambridge
Research interests
-
Lymphoma
-
Immunotherapy
-
Biomarkers
Research impacts
The research of the Blood Cancer Research Laboratory aims to understand the basis of lymphoma; to devise new treatments which are less toxic and more effective; to establish new biomarkers which will help determine the most effective treatment strategies and to monitor response and relapse and understand the development of lymphomas. The group has a strong emphasis on patient material, which it obtains from international and national clinical collaborators. Lymphomas studied include Hodgkin Lymphoma, PTLD, Diffuse Large B-cell Lymphoma, Follicular Lymphoma and virus associated lymphomas. We utilise a broad range of approaches including genomics, molecular and cellular biology techniques and functional immunoassays. Several of our studies are linked with the Australasian Leukaemia and Lymphoma Group.
The Mater Foundation, the Leukaemia Foundation, and the Brisbane Girls Grammar School Kirsten Jack Memorial Fund are thanked for their kind support.
Works
Search Professor Maher Gandhi’s works on UQ eSpace
1997
Conference Publication
Pre-autologous bone marrow transplant (ABMT) screening for HLA antibodies does not predict for platelet alloimmunization post-ABMT: A case controlled study
Gandhi, MK, Simpson, D, Yee, K, MacKinnon, J, Stewart, AK, Crump, M and Keating, A (1997). Pre-autologous bone marrow transplant (ABMT) screening for HLA antibodies does not predict for platelet alloimmunization post-ABMT: A case controlled study. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD.
1997
Conference Publication
Qualitative difference in CD34 counts in multiple myeloma (MM) and breast cancer (BCa) patient (PT) stem cell grafts.
Simpson, DR, Gandhi, MK, Stewart, AK, Crump, M and Keating, A (1997). Qualitative difference in CD34 counts in multiple myeloma (MM) and breast cancer (BCa) patient (PT) stem cell grafts.. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD.
1997
Conference Publication
Autologous marrow and/or blood cell transplantation (ABMT) for follicular large cell lymphoma (FLC)
Simpson, DR, Gandhi, MK, Stewart, AK, Crump, M and Keating, A (1997). Autologous marrow and/or blood cell transplantation (ABMT) for follicular large cell lymphoma (FLC). CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD.
1997
Conference Publication
Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSF
Yee, K, Tu, JV, MacKinnon, J, Gandhi, M, Stewart, AK, Saragosa, R, Keating, A and Crump, M (1997). Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSF. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD.
1996
Conference Publication
Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up.
Keating, A, Gandhi, MK, Crump, M, Smith, A, Belch, A and Baker, MA (1996). Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up.. PHILADELPHIA: W B SAUNDERS CO.
1996
Conference Publication
A multicentre study of granulocyte-macrophage colony stimulating factor (GM-CSF) in combination with consolidation therapy in adult acute myeloid leukemia (AML).
Keating, A, Gandhi, MK, Crump, M, Smith, A, Belch, A and Baker, MA (1996). A multicentre study of granulocyte-macrophage colony stimulating factor (GM-CSF) in combination with consolidation therapy in adult acute myeloid leukemia (AML).. PHILADELPHIA: W B SAUNDERS CO.
1996
Conference Publication
Congenital deficiency of thiopurine methyltransferase as a cause of pancytopenia in patients treated with azathioprine
Hall, AG, Rabello, C, Jackson, G, Gandhi, MK and OBrien, H (1996). Congenital deficiency of thiopurine methyltransferase as a cause of pancytopenia in patients treated with azathioprine. OXFORD: BLACKWELL SCIENCE LTD.
1996
Journal Article
The Alder-Reilly anomaly in association with the myelodysplastic syndrome
Gandhi, MK, Howard, MR and Hamilton, PJ (1996). The Alder-Reilly anomaly in association with the myelodysplastic syndrome. Clinical and Laboratory Haematology, 18 (1), 39-40.
1995
Journal Article
An Unusual Case of Hypersomnolence Syndrome
Gandhi, MK and Chandler, JE (1995). An Unusual Case of Hypersomnolence Syndrome. Clinical and Laboratory Haematology, 17 (3), 247-250. doi: 10.1111/j.1365-2257.1995.tb01245.x
1993
Journal Article
A Case of Transfusion-Acquired Hepatitis-C
Wreghitt, TG, Gandhi, MK, Gray, JJ, Blagdon, J, Rankin, A and Coates, PB (1993). A Case of Transfusion-Acquired Hepatitis-C. Clinical and Laboratory Haematology, 15 (2), 141-144. doi: 10.1111/j.1365-2257.1993.tb00138.x
1993
Journal Article
Inducing Remission in Drug-Resistant Acute Myeloid-Leukemia with Cyclosporine-a
Gandhi, MK, Keidan, AJ, Rees, Jkh, Twentyman, P and Coates, PB (1993). Inducing Remission in Drug-Resistant Acute Myeloid-Leukemia with Cyclosporine-a. Clinical and Laboratory Haematology, 15 (3), 219-221. doi: 10.1111/j.1365-2257.1993.tb01085.x
Funding
Supervision
Availability
- Professor Maher Gandhi is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Personalised therapy for lymphoma
Principal Advisor
Other advisors: Honorary Professor Kristen Radford
-
Doctor Philosophy
Metabolic Reprogramming of Malignant B-cells Impairs Immune-Fitness of Intratumoral T-Cells in Follicular Lymphoma
Principal Advisor
Other advisors: Dr Joshua Tobin, Dr Soi Law
-
Doctor Philosophy
Impact of genetics upon the tumour microenvironment in Follicular Lymphoma
Principal Advisor
Other advisors: Dr Joshua Tobin, Dr Soi Law, Associate Professor Colm Keane
-
Doctor Philosophy
Investigations in the development of cord blood derived, GMP grade cellular immunotherapies
Associate Advisor
Other advisors: Honorary Professor Kristen Radford
-
Doctor Philosophy
Development of novel vaccines for cancer immunotherapy
Associate Advisor
Other advisors: Dr Kelvin Tuong, Honorary Professor Kristen Radford
Completed supervision
-
2022
Doctor Philosophy
A Comprehensive Study of Intratumoural T-cells in Follicular Lymphoma
Principal Advisor
Other advisors: Dr Soi Law, Associate Professor Colm Keane
-
2021
Doctor Philosophy
Clinical and Prognostic Tools to Improve Frontline Management Strategies in Follicular Lymphoma
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
2020
Doctor Philosophy
The impact of deficient antigen presentation on the tumour microenvironment of diffuse large B cell lymphoma
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
-
2019
Doctor Philosophy
A LABORATORY STUDY OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
2016
Master Philosophy
Killer cell Immunoglobulin-like Receptors in Immune Thrombocytopenia (ITP)
Principal Advisor
-
2013
Doctor Philosophy
Novel strategies for monitoring, treating and preventing Epstein Barr virus-associated Lymphomas
Principal Advisor
-
2020
Doctor Philosophy
Characterising miRNA - gene network associated with natural killer cell activation
Associate Advisor
Other advisors: Dr Soi Law
-
2019
Doctor Philosophy
Deciphering the structure and function of class I cytokine receptors: GHR and GP130
Associate Advisor
Other advisors: Associate Professor Andrew Brooks
-
2013
Doctor Philosophy
IRE1-mediated splicing of xbp1 in Natural Killer cells
Associate Advisor
Media
Enquiries
Contact Professor Maher Gandhi directly for media enquiries about:
- Biomarkers
- Immunotherapy
- Lymphoma
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: